Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Stable Isotope Labelled Tarextumab Biosimilar - Anti-CD52 mAb - Research Grade |
---|---|
Source | CAS 1359940-55-8 |
Species | Caninized |
Expression system | Mammalian cells |
Purity | >95% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | MS |
Aliases /Synonyms | OMP-59R5 |
Reference | PX-TA1326-SIL |
Related Products | PX-P4074 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG2-kappa-lambda |
Clonality | Monoclonal Antibody |
Format | Lyophilized |
Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
Isotopic Enrichment | 99% |
Stability | 1 year |
Tarextumab has beeninvestigated for the treatment of Solid Tumors, Stage IV Pancreatic Cancer, and Stage IV Small Cell Lung Cancer.
Reviews
Il n’y a pas encore d’avis.